Showing results (551-560 of 619) with videos related to

Sort By:
Pageof 62
Antimicrobial Agents and Chemotherapy|August 24, 2016
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2018
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based ModelingRajbharan Yadav, Kate E Rogers, Phillip J Bergen, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Emerging Infectious Diseases|August 25, 2004
Phylogenetic analysis of West Nile virus, Nuevo Leon State, MexicoBradley J Blitvich, Ildefonso Fernández-Salas, Juan F Contreras-Cordero, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2024
Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment?Carleigh Duke, Suzanne L Parker, Betty B Zam, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2023
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic studyDanny Tsai, Betty B Zam, Carleigh Tongs, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection ModelPhillip J Bergen, Jürgen B Bulitta, Carl M J Kirkpatrick, et al.
Emerging Infectious Diseases|August 2, 2003
Serologic evidence of West Nile virus infection in horses, Yucatan State, MexicoMaría A Loroño-Pino, Bradley J Blitvich, José A Farfán-Ale, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2019
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill PatientsRajbharan Yadav, Phillip J Bergen, Kate E Rogers, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Pageof 62